We also used the ALKBH1 gene for Cox regression analysis and found that its expression can effectively be used to analyze and predict the survival of PAAD patients; the AUC at 1 and 3 years was greater than 0.55, and the P-value of patient risk prediction was less than 0.0001 (Figure 5D,E, all P<0.001). Here, ALKBH1 is linked to pancreatic adenocarcinoma.